French Sanofi retains patent for Toujeo long-acting insulin glargine
Russian "Geropharm" once again failed to challenge the patent for long-acting insulin glargine "Tujeo", produced by the French Sanofi. This...
Russian "Geropharm" once again failed to challenge the patent for long-acting insulin glargine "Tujeo", produced by the French Sanofi. This...
One of the major European insulin manufacturers Novo Nordisk, following the American BMS and Eli Lilly, may transfer the supply...